A Prospective, Multicenter, Phase 2 Study of Imatinib Mesylate in Korean Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumor

Oncology ◽

10.1159/000209384 ◽

2009 ◽

Vol 76 (5) ◽

pp. 326-332 ◽

Author(s):

Min-Hee Ryu ◽

Won Ki Kang ◽

Yung-Jue Bang ◽

Kyung Hee Lee ◽

Dong Bok Shin ◽

...

Keyword(s):

Gastrointestinal Stromal Tumor ◽

Imatinib Mesylate ◽

Stromal Tumor ◽

Phase 2 ◽

Korean Patients ◽

Multicenter Phase ◽

Download Full-text

Faculty Opinions recommendation of Phase 2 study of nilotinib as third-line therapy for patients with gastrointestinal stromal tumor.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9736957.10424054 ◽

2011 ◽

Author(s):

Florence Duffaud

Keyword(s):

Gastrointestinal Stromal Tumor ◽

Stromal Tumor ◽

Phase 2 ◽

Line Therapy ◽

Phase 2 Study ◽

Third Line Therapy ◽

Download Full-text

Phase 2 study of nilotinib as third-line therapy for patients with gastrointestinal stromal tumor

Cancer ◽

10.1002/cncr.26120 ◽

2011 ◽

Vol 117 (20) ◽

pp. 4633-4641 ◽

Author(s):

Akira Sawaki ◽

Toshirou Nishida ◽

Toshihiko Doi ◽

Yasuhide Yamada ◽

Yoshito Komatsu ◽

...

Keyword(s):

Gastrointestinal Stromal Tumor ◽

Stromal Tumor ◽

Phase 2 ◽

Line Therapy ◽

Phase 2 Study ◽

Third Line Therapy ◽

Download Full-text

A Prospective Multicenter Phase 2 Study of FCR/BR Alternating With Ibrutinib in Treatment-naive Patients With CLL

Case Medical Research ◽

10.31525/ct1-nct03980002 ◽

2019 ◽

Author(s):

Keyword(s):

Phase 2 ◽

Multicenter Phase ◽

Phase 2 Study ◽

Treatment Naïve

Download Full-text

Faculty Opinions recommendation of Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718390800.793495363 ◽

2014 ◽

Author(s):

James Bussel

Keyword(s):

Immune Thrombocytopenic Purpura ◽

Phase 2 ◽

Efficacy And Safety ◽

Thrombocytopenic Purpura ◽

Chronic Immune Thrombocytopenic Purpura ◽

Multicenter Phase ◽

Download Full-text

Faculty Opinions recommendation of A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725819857.793510074 ◽

2015 ◽

Author(s):

Marilyn Telen

Keyword(s):

Sickle Cell Disease ◽

Sickle Cell ◽

Adult Patients ◽

Phase 2 ◽

Cell Disease ◽

Double Blind ◽

Multicenter Phase ◽

Download Full-text

P-95 EV-202: An open-label, multicenter, phase 2 study of enfortumab vedotin in patients with previously treated locally advanced or metastatic solid tumors, including upper gastrointestinal cancers

Annals of Oncology ◽

10.1016/j.annonc.2021.05.150 ◽

2021 ◽

Vol 32 ◽

pp. S130

Author(s):

K. Muro ◽

J. Bruce ◽

J. Baranda ◽

S. Gorla ◽

C. Wu ◽

...

Keyword(s):

Solid Tumors ◽

Locally Advanced ◽

Phase 2 ◽

Gastrointestinal Cancers ◽

Multicenter Phase ◽

Phase 2 Study ◽

Previously Treated ◽

Upper Gastrointestinal

Download Full-text

Phase 2 Trial to Evaluate the Efficacy and Safety of Dovitinib in Patients (Pts) with Gastrointestinal Stromal Tumor (Gist) Refractory and/or Intolerant to Imatinib (Im)

Annals of Oncology ◽

10.1093/annonc/mdu438.58 ◽

2014 ◽

Vol 25 ◽

pp. v1 ◽

Author(s):

H. Joensuu ◽

J-Y. Blay ◽

A. Comandone ◽

J. Martin Broto ◽

E. Fumagalli ◽

...

Keyword(s):

Gastrointestinal Stromal Tumor ◽

Stromal Tumor ◽

Phase 2 ◽

Efficacy And Safety ◽

Download Full-text

Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first-line treatment of patients with advanced HER2-negative gastric cancer: A multicenter phase 2 study

Cancer ◽

10.1002/cncr.29864 ◽

2016 ◽

Vol 122 (9) ◽

pp. 1434-1443 ◽

Author(s):

Didier Meulendijks ◽

Jan Willem B. de Groot ◽

Maartje Los ◽

James E. Boers ◽

Laurens V. Beerepoot ◽

...

Keyword(s):

Gastric Cancer ◽

Line Treatment ◽

Phase 2 ◽

Multicenter Phase ◽

Phase 2 Study ◽

First Line Treatment

Download Full-text

Rg-101 in Combination With 4 Weeks of Oral Direct Acting Antiviral Therapy Achieves High Virologic Response Rates in Treatment Naïve Genotype 1 and 4 Chronic Hepatitis C Patients: Interim Results from a Randomised, Multicenter, Phase 2 Study

Journal of Hepatology ◽

10.1016/s0168-8278(16)01665-2 ◽

2016 ◽

Vol 64 (2) ◽

pp. S159 ◽

Author(s):

G. Horvath ◽

G. Papatheodoridis ◽

M. Fabri ◽

M. Makara ◽

P. Grint ◽

...

Keyword(s):

Chronic Hepatitis ◽

Virologic Response ◽

Phase 2 ◽

Direct Acting Antiviral ◽

Multicenter Phase ◽

Phase 2 Study ◽

Treatment Naïve ◽

Direct Acting ◽

Chronic Hepatitis C Patients

Download Full-text

Gynecomastia during imatinib mesylate treatment for gastrointestinal stromal tumor: a rare adverse event

BMC Gastroenterology ◽

10.1186/1471-230x-11-116 ◽

2011 ◽

Vol 11 (1) ◽

Author(s):

HeLi Liu ◽

GuoQing Liao ◽

ZhongShu Yan

Keyword(s):

Adverse Event ◽

Gastrointestinal Stromal Tumor ◽

Imatinib Mesylate ◽

Download Full-text